Alkahest Overview
- Year Founded
-
2014
- Status
-
Acquired/Merged
- Employees
-
71
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$146M
Alkahest General Information
Description
Owner and operator of a biotechnology company intended to enrich the health and vitality of humankind through transformative therapies that counterbalance the aging process. The company's therapies are used to augment the factors in the blood plasma in order to reverse the detrimental effects of aging in both normal aging and disease models in animals, enabling doctors to improve vitality and find treatment for diseases of aging.
Contact Information
Website
www.alkahest.com(Operating Subsidiary)
Corporate Office
- 75 Shoreway Road
- Suite D
- San Carlos, CA 94070
- United States
Corporate Office
- 75 Shoreway Road
- Suite D
- San Carlos, CA 94070
- United States
Alkahest Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 15-Dec-2020 | $146M | Completed | Generating Revenue | ||
| 3. Grant | 12-Feb-2018 | Completed | Clinical Trials - Phase 2 | |||
| 2. Early Stage VC | 23-Nov-2015 | $35.9M | $39.4M | Completed | Clinical Trials - Phase 2 | |
| 1. Early Stage VC (Series A) | 10-Jul-2014 | $3.5M | $3.5M | Completed | Clinical Trials - Phase 2 |
Alkahest Comparisons
Industry
Financing
Details
Alkahest Competitors (71)
One of Alkahest’s 71 competitors is Casma Therapeutics, a Venture Capital-Backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Casma Therapeutics | Venture Capital-Backed | Cambridge, MA | ||||
| NewLimit | Venture Capital-Backed | South San Francisco, CA | ||||
| Mighty Therapeutics | Private Equity-Backed | Needham, MA | ||||
| Orchard Therapeutics | Formerly VC-backed | London, United Kingdom | ||||
| KalGene Inc | Venture Capital-Backed | Montreal, Canada |
Alkahest Patents
Alkahest Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026151932-A1 | Medical diagnosis, prognosis and prediction of treatment using multiplexed signatures | Pending | 09-Jan-2025 | ||
| AU-2025266331-A1 | Compositions of blood plasma fractions and their use in treatment of spinal muscular atrophy (sma) | Pending | 29-Apr-2024 | ||
| EP-4827876-A1 | Compositions of blood plasma fractions and their use in treatment of spinal muscular atrophy (sma) | Pending | 29-Apr-2024 | ||
| WO-2025230830-A1 | Compositions of blood plasma fractions and their use in treatment of spinal muscular atrophy (sma) | Pending | 29-Apr-2024 | ||
| AU-2025238746-A1 | Longitudinal sample sets and methods of making and using the same | Pending | 20-Mar-2024 | G16H50/20 |
Alkahest Signals
Alkahest Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Michael J. Fox Foundation | Limited Partner | |||
| Nan Fung Life Sciences | Venture Capital | Minority | ||
| Pivotal bioVenture Partners | Venture Capital | Minority |
Alkahest FAQs
-
When was Alkahest founded?
Alkahest was founded in 2014.
-
Where is Alkahest headquartered?
Alkahest is headquartered in San Carlos, CA.
-
What is the size of Alkahest?
Alkahest has 71 total employees.
-
What industry is Alkahest in?
Alkahest’s primary industry is Drug Discovery.
-
Is Alkahest a private or public company?
Alkahest is a Private company.
-
What is the current valuation of Alkahest?
The current valuation of Alkahest is .
-
What is Alkahest’s current revenue?
The current revenue for Alkahest is .
-
How much funding has Alkahest raised over time?
Alkahest has raised $39.4M.
-
Who are Alkahest’s investors?
Michael J. Fox Foundation, Nan Fung Life Sciences, and Pivotal bioVenture Partners have invested in Alkahest.
-
Who are Alkahest’s competitors?
Casma Therapeutics, NewLimit, Mighty Therapeutics, Orchard Therapeutics, and KalGene Inc are some of the 71 competitors of Alkahest.
-
When was Alkahest acquired?
Alkahest was acquired on 15-Dec-2020.
-
Who acquired Alkahest?
Alkahest was acquired by Grifols.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process